Pfizer expects results from its coronavirus vaccine trials by October, CEO confirms
Pfizer Inc says it could have results from its late-stage coronavirus vaccine trial available as early as October. On Thursday, CEO Albert Bourla said during a call sponsored by drug industry group International Federation of Pharmaceutical Manufacturers & Associations that 23,000 volunteers have been enrolled in the phase III trial, which began in July. The … Read more